News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,298 Results
Type
Article (15955)
Company Profile (66)
Press Release (280269)
Multimedia
Podcasts (111)
Webinars (15)
Section
Business (108682)
Career Advice (1068)
Deals (17848)
Drug Delivery (148)
Drug Development (20433)
Employer Resources (68)
FDA (5723)
Job Trends (7233)
News (141526)
Policy (13650)
Tag
2025 Best Places to Work (5)
2026 Best Places to Work (9)
2027 BioCapital Standard (4)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 NextGen (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (3)
40 Under 40 (1)
Academia (974)
Accelerated approval (24)
ADA (18)
Adcomms (29)
Allergies (82)
Alliances (26898)
ALS (83)
Alzheimer's disease (637)
Antibody-drug conjugate (ADC) (245)
Approvals (5839)
Artificial intelligence (505)
ASCO (94)
Autoimmune disease (142)
Automation (42)
Bankruptcy (157)
Belgium (29)
Best Places to Work (5559)
BIO (37)
Biologics (48)
BIOSECURE Act (16)
Biosimilars (153)
BioSpace Insights (84)
Biotechnology (35)
Bispecific (16)
Bladder cancer (76)
Brain cancer (22)
Breast cancer (243)
Cancer (2491)
Cardiovascular disease (263)
Career advice (913)
Career pathing (38)
CAR-T (137)
CDC (59)
CDMO (148)
Celiac Disease (3)
Cell-line development (1)
Cell therapy (412)
Cervical cancer (20)
Clinical research (18155)
Collaboration (1373)
Commercialization (43)
Company closure (5)
Compensation (1115)
Complete response letters (49)
COVID-19 (1068)
CRISPR (40)
CRO (9)
C-suite (767)
Cystic fibrosis (26)
Data (2778)
Decentralized trials (3)
Denatured (19)
Depression (85)
Dermatology (95)
Diabetes (256)
Diagnostics (3956)
Digital health (43)
Diversity (10)
Diversity, equity & inclusion (18)
Drug discovery (248)
Drug pricing (205)
Drug shortages (31)
Duchenne muscular dystrophy (130)
Earnings (35244)
Editorial (64)
Employer branding (8)
Employer resources (72)
ESMO (68)
Events (36578)
Executive appointments (664)
Eye disease (10)
FDA (7362)
Fibrodysplasia Ossificans Progressiva (2)
Fragile X (1)
Friedreich's ataxia (7)
Frontotemporal dementia (7)
Funding (835)
Gene editing (83)
Generative AI (51)
Gene therapy (302)
GLP-1 (661)
Government (2910)
Grass and pollen (6)
Guidances (242)
Healthcare (9724)
Hematology (77)
HIV (49)
Huntington's disease (25)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (30)
Immunology and inflammation (196)
Immuno-oncology (62)
Indications (77)
Infectious disease (1271)
Inflammatory bowel disease (104)
Inflation Reduction Act (12)
Influenza (71)
Intellectual property (106)
Interviews (167)
IPO (7161)
IRA (51)
Job creations (1642)
Job search strategy (753)
JPM (40)
Kidney cancer (5)
Kidney disease (51)
Labor market (107)
Layoffs (329)
Leadership (38)
Legal (2908)
Licensing (54)
Liver cancer (34)
Longevity (22)
Lung cancer (329)
Lung diease (12)
Lymphoma (204)
Machine learning (34)
Management (31)
Manufacturing (1005)
Marketing (16)
MASH (104)
Medical affairs (2)
Medical device (5479)
Medtech (5589)
Melanoma (96)
Mergers & acquisitions (11447)
Metabolic disorders (866)
Middle East (1)
mRNA (102)
Multiple sclerosis (79)
Multispecific (2)
NASH (12)
Netherlands (20)
Neurodegenerative disease (174)
Neuropsychiatric disorders (65)
Neuroscience (1337)
Neurotech (1)
NextGen: Class of 2026 (3531)
Non-profit (2463)
Now hiring (63)
Obesity (505)
Opinion (218)
Ovarian cancer (48)
Pain (134)
Pancreatic cancer (127)
Parkinson's disease (122)
Partnered (26)
Patents (248)
Patient advocacy (5)
Patient recruitment (213)
Patient selection (25)
Peanut (21)
People (30090)
Peptides (18)
Pharmaceutical (23)
Pharmacy benefit managers (32)
Phase 1 (4921)
Phase 2 (7964)
Phase 3 (6862)
Pipeline (5452)
Policy (311)
Postmarket research (634)
Preclinical (1833)
Press Release (68)
Prostate cancer (151)
Psychedelics (51)
Radioligand (1)
Radiopharmaceuticals (195)
Rare diseases (499)
Real estate (3688)
Recruiting (33)
Regenerative medicine (8)
Regulatory (10652)
Reports (38)
Research institute (980)
Resumes & cover letters (179)
Rett syndrome (5)
RNA editing (11)
RSV (42)
Schizophrenia (106)
Series A (110)
Series B (79)
Service/supplier (12)
Sickle cell disease (48)
Special edition (29)
Spinal muscular atrophy (60)
Sponsored (24)
Startups (1551)
State (1)
Stem cells (3)
Stomach cancer (12)
Substance use disorders (7)
Supply chain (112)
Switzerland (11)
Tariffs (101)
Tax incentives (1)
The Weekly (90)
Vaccines (449)
Venture capital (108)
Weight loss (394)
Wet AMD (4)
Women's health (79)
Women in leadership (1)
Worklife (15)
Date
Last 7 days (254)
Last 30 days (1277)
Last 365 days (11861)
2026 (11027)
2025 (11644)
2024 (13838)
2023 (15907)
2022 (22883)
2021 (23985)
2020 (24464)
2019 (23729)
2018 (18090)
2017 (14692)
2016 (13923)
2015 (15008)
2014 (10386)
2013 (8941)
2012 (9690)
2011 (10094)
2010 (8720)
Location
Africa (386)
Alabama (27)
Alaska (4)
Arizona (143)
Arkansas (10)
Asia (18361)
Australia (2074)
California (4837)
Canada (2527)
China (698)
Colorado (381)
Connecticut (279)
Delaware (138)
Europe (44358)
Florida (938)
Georgia (166)
Hawaii (4)
Idaho (25)
Illinois (663)
India (91)
Indiana (247)
Iowa (10)
Japan (359)
Kansas (94)
Kentucky (43)
Louisiana (35)
Maine (34)
Maryland (876)
Massachusetts (3529)
Michigan (207)
Minnesota (261)
Mississippi (5)
Missouri (81)
Montana (11)
Nebraska (16)
Nevada (76)
New Hampshire (28)
New Jersey (1879)
New Mexico (24)
New York (1194)
North Carolina (952)
North Dakota (6)
Northern California (2235)
Ohio (278)
Oklahoma (18)
Oregon (15)
Pennsylvania (1456)
Puerto Rico (27)
Rhode Island (25)
South America (564)
South Carolina (22)
South Dakota (1)
Southern California (2172)
Tennessee (129)
Texas (922)
United States (20023)
Utah (119)
Vermont (2)
Virginia (114)
Washington D.C. (39)
Washington State (474)
West Virginia (4)
Wisconsin (97)
Wyoming (3)
296,298 Results for "nuvisan pharma services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biovica Announces Change in Pharma Services Leadership as it Strengthens its Pharma Offering
October 6, 2026
·
2 min read
Press Releases
Biovica Expands Pharma Services Business with New Master Services Agreement
August 27, 2026
·
1 min read
Press Releases
LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical and GLP Bioanalytical Services
October 22, 2026
·
6 min read
Press Releases
Aptar Pharma Expands Services Capabilities to Support Development of Inhaled and Nasal Drug Products Containing Controlled Substances
November 13, 2026
·
2 min read
Press Releases
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization
October 5, 2026
·
2 min read
Press Releases
Biovica Receives New Extensive Pharma Services Work Order from Existing Customer
August 19, 2026
·
2 min read
Mergers & acquisitions
5 acquisitions that forced Big Pharmas to co-parent
Acquiring a biotech with an existing Big Pharma partner can impose financial and strategic constraints around data sharing and milestone and royalty payments—but it is “rarely a deal-breaker,” according to one biotech consultant.
November 18, 2026
·
8 min read
·
Tristan Manalac
Job Trends
Behind the scenes of 3 Big Pharma layoffs
Three former employees of large pharmas, including Novo and Sanofi, share how they were let go. While they appreciated some aspects of their experiences, such as severance and outplacement resources, they criticized a lack of public transparency, a mishandled notification and puzzling outsourcing.
October 28, 2026
·
5 min read
·
Angela Gabriel
Manufacturing
Sun Pharma stops eye-care drug production at Indian plant amid quality issues
The cessation of manufacturing activities follows a Sun Pharma recall and reports that regulators found fault with the company’s quality system.
November 2, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Big Pharma is ready to strike, with J&J most likely to buy: Leerink
The largest pharmas have a collective $188 billion in firepower to spend on M&A transactions, with all but one signaling a desire to execute, according to a new analysis from Leerink Partners.
October 28, 2026
·
3 min read
·
Annalee Armstrong
1 of 29,630
Next